Related Experiment Video
Updated: Jun 24, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
[Prevention of contrast-induced nephropathy and management of high-risk patients]
1Centro Cardiologico Monzino, IRCCS, Istituto di Cardiologia, Università degli Studi, Milano. giancarlo.marenzi@ccfm.it
Insights
Contrast-induced nephropathy (CIN) is a common complication of radiological procedures using iodinated contrast media. Prevention is key due to lack of effective treatments, especially in patients undergoing percutaneous coronary interventions.
Area of Science:
- Nephrology
- Radiology
- Cardiology
Context:
- Radiological procedures using intravascular iodinated contrast media are prevalent for diagnosis and therapy.
- These procedures are a leading cause of contrast-induced nephropathy (CIN) and hospital-acquired renal failure.
- CIN presents significant morbidity, mortality, and increased healthcare costs.
Purpose:
- To review risk factors and clinical course of CIN.
- To examine recent advancements in CIN prevention strategies.
- To discuss potential therapeutic interventions for CIN, particularly in percutaneous coronary interventions.
Summary:
- Contrast-induced nephropathy (CIN) is a significant iatrogenic complication of intravascular iodinated contrast media used in radiological procedures.
- Effective prevention strategies are crucial as current treatments for CIN are limited.
- Patients undergoing percutaneous coronary interventions are at high risk due to comorbidities, making CIN prevention a major clinical concern.
Impact:
- Highlights the critical need for effective CIN prevention protocols.
- Informs clinical practice regarding risk assessment and management of patients undergoing contrast-enhanced radiological procedures.
- Emphasizes the importance of further research into novel preventive and therapeutic approaches for CIN.
Abstract:
Radiological procedures that utilize intravascular iodinated contrast media are being widely applied for both diagnostic and therapeutic purposes and represent one of the main causes of contrast-induced nephropathy (CIN) and hospital-acquired renal failure. Owing to the lack of any effective treatment, prevention of this iatrogenic disease, which is associated with significant in-hospital and long-term morbidity and mortality and increased costs, is the key strategy. However, prevention of CIN continues to elude clinicians and is a main concern during percutaneous coronary interventions, as patients undergoing these procedures often have multiple comorbidities. The purpose of this article is to examine the risk factors and clinical course of CIN, as well as the most recent studies dealing with its prevention and potential therapeutic interventions, especially during percutaneous coronary interventions.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury V: Interprofessional Care